Literature DB >> 22391326

Hydrogen sulfide producing enzymes in pregnancy and preeclampsia.

K M Holwerda1, E M Bos, A Rajakumar, C Ris-Stalpers, M G van Pampus, A Timmer, J J H M Erwich, M M Faas, H van Goor, A T Lely.   

Abstract

Preeclampsia, a human pregnancy specific disorder is characterized by an anti-angiogenic state. As hydrogen sulfide (H(2)S) has pro-angiogenic and anti-oxidative characteristics, we hypothesized that H(2)S levels could play a role in the pathogenesis of preeclampsia and studied the placental expression of the H(2)S-producing enzymes cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS). CBS and CSE protein are expressed in the fetal-placental endothelium and CBS only in Hofbauer cells. CBS mRNA expression is decreased (p = 0.002) in early-onset preeclampsia, while CSE mRNA is unchanged. Thus, down regulation of CBS during early-onset preeclampsia may result in less H(2)S-production and may aid in the anti-angiogenic state.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391326     DOI: 10.1016/j.placenta.2012.02.014

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  28 in total

1.  Placental Stem Villus Arterial Remodeling Associated with Reduced Hydrogen Sulfide Synthesis Contributes to Human Fetal Growth Restriction.

Authors:  Liangjian Lu; John Kingdom; Graham J Burton; Tereza Cindrova-Davies
Journal:  Am J Pathol       Date:  2017-02-01       Impact factor: 4.307

2.  Temporal expression of genes involved in folate metabolism and transport during placental development, preeclampsia and neural tube defects.

Authors:  Palani Selvam Mohanraj; Beenish Rahat; Aatish Mahajan; Rashmi Bagga; Jyotdeep Kaur
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

Review 3.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor.

Authors:  Kim M Holwerda; Suzanne D Burke; Marijke M Faas; Zsuzsanna Zsengeller; Isaac E Stillman; Peter M Kang; Harry van Goor; Amy McCurley; Iris Z Jaffe; S Ananth Karumanchi; A Titia Lely
Journal:  J Am Soc Nephrol       Date:  2013-12-12       Impact factor: 10.121

Review 5.  Gasotransmitters in pregnancy: from conception to uterine involution.

Authors:  Damian D Guerra; K Joseph Hurt
Journal:  Biol Reprod       Date:  2019-07-01       Impact factor: 4.285

Review 6.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

Review 7.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

Review 8.  Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.

Authors:  Guoliang Meng; Yan Ma; Liping Xie; Albert Ferro; Yong Ji
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 9.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

10.  Human trophoblast-derived hydrogen sulfide stimulates placental artery endothelial cell angiogenesis.

Authors:  Dong-Bao Chen; Lin Feng; Jennifer K Hodges; Thomas J Lechuga; Honghai Zhang
Journal:  Biol Reprod       Date:  2017-09-01       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.